The CEO of the biopharmaceutical company AbbVie Italy, Fabrizio Greco, was appointed president of the Italian American Pharmaceutical Group for another two years (iapg), a position he has held since June 2017.
The IAPG brings together the 15 largest pharmaceutical companies made in the USA operating in Italy. According to Farmindustria, in 2019 the companies of the group produced revenues of 9 billion euros, equal to 26% of the entire Italian pharmaceutical sector. The value of exported goods, on the other hand, amounts to 3,2 billion euros, a figure that has almost doubled in the last three years.
As regards pharmaceutical companies with US capital, Italy is the first country in the entire EU in terms of production and employment. In all, the companies involved employ 13 people (plus the same number in related industries), half of whom are involved in research and development, a sector in which 57% of investments are concentrated.
In the past, Fabrizio Greco held the role of Chief Executive Officer of Abbott in Italy, after having been General Manager of Abbott Vascular Italy. Previously he had assumed positions of increasing responsibility in Guidant until he became General Manager of the subsidiary in Portugal.
"In a particularly critical moment like the current one - comments Greco - we have all understood the importance of collaboration, transparency and sharing of priority objectives for the country and the pharmaceutical industry has done its part by guaranteeing continuity both in economic terms- productive and supportive of citizens' health".
“The coming months will represent a moment of discontinuity with the past – concludes the manager – in which we will have to define the foundations for the future of the country and of our sector. It is necessary to draw on recent experiences and tackle, with the same method, responsibility and courage, fundamental aspects of the pharmaceutical sector which for years have been waiting for adequate answers to allow the sustainability of the healthcare system, of companies and above all to satisfy the health needs of citizens" .
